Careful analysis of an unusual precipitate identifies defects.
Shwu-Maan Lee, PhD
Advertisement
Shwu-Maan Lee, PhD, is a technical director at Baxter Healthcare.
Articles by Shwu-Maan Lee, PhD
How to balance porosity, plugging, and lot-to-lot variability in filters.
NeisVac-C is a polysaccharide-protein conjugate vaccine for use against Neisseria meningitidis serogroup C infection. The Phase 1 clinical formulation consisted of physiological saline, thimerosal, and aluminum hydroxide. The long-term stability data for both the PBS and saline formulations are presented in this article.
Advertisement
Latest Updated Articles
Meningitis Vaccine Manufacturing: Fermentation Harvest Procedures Affect PurificationPublished: April 2nd 2011 | Updated:
Meningitis Vaccine Purification: Quality Control of Ultrafiltration Membrane PorosityPublished: August 1st 2010 | Updated:
Formulation Studies of an Adsorbed Conjugate VaccinePublished: October 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
